These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7700642)

  • 1. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
    Müller E; Scheidtmann KH
    Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L; Meek DW
    Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of casein kinase II with immunopurified p53.
    Herrmann CP; Kraiss S; Montenarh M
    Oncogene; 1991 May; 6(5):877-84. PubMed ID: 2052362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme.
    Milne DM; Palmer RH; Campbell DG; Meek DW
    Oncogene; 1992 Jul; 7(7):1361-9. PubMed ID: 1620549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyomavirus large T antigen overcomes p53 dependent growth arrest.
    Doherty J; Freund R
    Oncogene; 1997 Apr; 14(16):1923-31. PubMed ID: 9150359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revertant of SV40-transformed cells.
    Deppert W; Kurth M; Graessmann M; Graessmann A; Knippschild U
    Oncogene; 1991 Oct; 6(10):1931-8. PubMed ID: 1923516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
    Hu MC; Qiu WR; Wang YP
    Oncogene; 1997 Nov; 15(19):2277-87. PubMed ID: 9393873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase activity associated with immunopurified p53 protein.
    Kraiss S; Barnekow A; Montenarh M
    Oncogene; 1990 Jun; 5(6):845-55. PubMed ID: 2141685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53.
    Salewski H; Bayer TA; Eidhoff U; Preuss U; Weggen S; Scheidtmann KH
    Cancer Res; 1999 Apr; 59(8):1980-6. PubMed ID: 10213510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of LT-antigen/p53 complex by heat treatment correlates with inhibition of DNA synthesis during transforming infection with SV40.
    Khandjian EW; Rose TM
    Biochem Cell Biol; 2000; 78(4):437-45. PubMed ID: 11012082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
    Fiscella M; Ullrich SJ; Zambrano N; Shields MT; Lin D; Lees-Miller SP; Anderson CW; Mercer WE; Appella E
    Oncogene; 1993 Jun; 8(6):1519-28. PubMed ID: 8502477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung.
    Daya-Makin M; Sanghera JS; Mogentale TL; Lipp M; Parchomchuk J; Hogg JC; Pelech SL
    Cancer Res; 1994 Apr; 54(8):2262-8. PubMed ID: 7513612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of SV40 large T antigen induced apoptosis by small T antigen.
    Kolzau T; Hansen RS; Zahra D; Reddel RR; Braithwaite AW
    Oncogene; 1999 Sep; 18(40):5598-603. PubMed ID: 10523837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
    J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of synthetic peptide substrates for p34cdc2 protein kinase.
    Marshak DR; Vandenberg MT; Bae YS; Yu IJ
    J Cell Biochem; 1991 Apr; 45(4):391-400. PubMed ID: 2045431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial transformation of human tumor cell lines showing defective interaction between unusual p53 gene product and SV40 large-T antigen.
    Van Roy F; Liebaut G; Mareel M; Fiers W
    Oncogene; 1990 Feb; 5(2):207-18. PubMed ID: 2157184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of murine p53, but not human p53, by MAP kinase in vitro and in cultured cells highlights species-dependent variation in post-translational modification.
    Jardine LJ; Milne DM; Dumaz N; Meek DW
    Oncogene; 1999 Dec; 18(52):7602-7. PubMed ID: 10602521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of a novel serine/threonine kinase that phosphorylates c-Fos upon stimulation of T and B lymphocytes via antigen and cytokine receptors.
    Nel AE; Taylor LK; Kumar GP; Gupta S; Wang SC; Williams K; Liao O; Swanson K; Landreth GE
    J Immunol; 1994 May; 152(9):4347-57. PubMed ID: 8157958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
    Messner DJ; Romeo C; Boynton A; Rossie S
    J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.